Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-30

Clinical Trial Update: To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Hypidone Hydrochloride Tablets in major depressive disorder, spanning Phase 1 and Phase 2, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypidone Hydrochloride Tablets (Hypidone hydrochloride)

Snippet

Sponsor: Zhejiang Huahai Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED